Albany, NY, Feb. 05, 2016 -- The Research Report states that the market, which had a valuation of US$4.8 billion in 2014, will expand at a moderate but positive 3.50% CAGR between 2015 and 2023 and rise to US$6.5 billion by 2023. In terms of volume, the market valued 1,846.1 kilo tons in 2014.
Browse Industry Research Report with free Analysis: http://www.transparencymarketresearch.com/rheology-modifiers-market.html
Rheology modifiers play a crucial role in controlling the rheology of fluids in a number of end-use industries such as adhesives and sealants, pharmaceuticals, paints and coatings, and construction. The report states that growth of the end-use industries, especially in Asia Pacific, will propel the global rheology market over the report’s forecast period.
However, the market’s growth is expected to be restricted to some extent owing to the declining demand for ink in the global market. Rising consumer preference for electronic publications such as e-papers, e-journals, e-books, and others is leading to a continuous reduction in the overall demand for inks in print media, hampering the overall development of the global rheology market.
Get Industry Research Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=7535
The report segments the global rheology market on the basis of three criteria: product type, application, and geography. Of the key product types studied in the report, the segment of organic rheology modifiers held the largest share in the global market in 2014. The segment of organic rheology modifiers primarily includes products such as xanthum gum, acrylic polymers, polyurethane, and microcrystalline cellulose. The segment of inorganic rheology modifiers includes products such as silica-based rheology modifiers and organo-clay.
Of the key application areas of rheology modifiers studied in the report, paints and coatings accounted for the largest share, an estimated 30%, in the global market in 2014. Over the report’s forecast period, application of rheology modifiers in the pharmaceutical industry is expected to grow at the fastest pace.
Of the key regional markets analyzed in the report, Asia Pacific accounted for more than one-third of the global market in 2014. China is one of largest manufacturers and consumers of rheology modifiers in Asia Pacific, primarily owing to the large industrial base of the country. Upcoming construction projects in North America and rising investments in research and development in industries such as personal care and pharmaceuticals in Europe are driving an increased demand for rheology modifiers in these regions.
Browse Research Article: http://www.transparencymarketresearch.com/article/rheology-modifiers-market.htm
The report also gives a crisp overview of the competitive landscape of the market with the help of business profiles of some of the key companies in the market and an analysis of some of the most crucial developments. The companies profiled in the report include The MÜNZING Group, Air Products and Chemicals, Inc., Altana AG, Akzo Nobel N.V., BASF SE, Arkema S.A., Clariant, Ashland Inc., Cargill Inc., Diransa San Luis S.A., Eastman Chemical Company, Croda International plc, The Dow Chemical Company, Global Drilling Fluids and Chemicals Limited, Evonik Industries AG, Elementis plc, SNF Holding Company, The Euclid Chemical Company, DuPont, FCC Inc., The Lubrizol Corporation, Hangzhou Jingyi Chemical Co., Ltd., Mallard Creek Polymers, Inc., San Nopco Limited, and PPG Industries, Inc.
The Rheology Modifiers Market has been segmented as follows:
Rheology Modifiers Market – Product Segment Analysis
- Organic
- Inorganic
Rheology Modifiers Market - Application Analysis
- Paints & Coatings
- Personal Care
- Adhesives & Sealants
- Textiles
- Pharmaceuticals
- Construction
- Pulp & Paper
- Others (Including Mining Chemicals, etc.)
Rheology Modifiers Market - Regional Analysis
North America
- S.
- Rest of North America
Europe
- K.
- Germany
- France
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- ASEAN
- Rest of Asia Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC
- South Africa
- Rest of Middle East & Africa
Other Industry Research Reportby TMR:
- Paints and Coatings Market: http://www.transparencymarketresearch.com/Paints-coatings-market.html
About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decisionmakers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Mr.Sudip.S 90 State Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: [email protected] Website: http://www.transparencymarketresearch.com/


South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
Italy Fines Apple €98.6 Million Over App Store Dominance
FDA Approves Mitapivat for Anemia in Thalassemia Patients
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study 



